Usman Azam - 29 Sep 2025 Form 4 Insider Report for Cue Biopharma, Inc. (CUE)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Usman Azam by Michael Meluzio, attorney-in-fact
Issuer symbol
CUE
Transactions as of
29 Sep 2025
Net transactions value
$0
Form type
4
Filing time
02 Oct 2025, 20:13:23 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Azam Usman CHIEF EXECUTIVE OFFICER, Director C/O CUE BIOPHARMA, INC., 40 GUEST STREET, BOSTON /s/ Usman Azam by Michael Meluzio, attorney-in-fact 02 Oct 2025 0002089768

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CUE Stock Option (right to buy) Award $0 +1,875,000 $0.000000 1,875,000 29 Sep 2025 Common Stock 1,875,000 $0.7200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option becomes exercisable in 48 monthly installments beginning on September 29, 2026.